Adicet Bio, Inc.
ACET
$9.57
-$0.16-1.64%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/4/2026
-
MarketBeat
9/8/2026
-
TipRanks
Wall Street Analysts See a 258.21% Upside in Adicet Bio (ACET): Can the Stock Really Move This High?
9/3/2026
-
Zacks Investment Research
9/3/2026
-
Zacks Investment Research
9/3/2026
-
MarketBeat
9/2/2026
-
GuruFocus
9/2/2026
-
Business Wire
9/2/2026
-
TipRanks
9/1/2026
-
The Cerbat Gem
9/1/2026
-
TipRanks
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
Business Wire
8/31/2026
-
Business Wire
8/31/2026
-
The Cerbat Gem
8/29/2026
-
MarketBeat
8/27/2026
-
TipRanks: TheFly
8/27/2026
-
GuruFocus
8/27/2026
-
Business Wire
8/26/2026
-
TipRanks
8/24/2026
-
MarketBeat
8/24/2026
-
Zacks Investment Research
8/18/2026
-
Zacks Investment Research
8/14/2026
-
SeekingAlpha
8/14/2026
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 503 9095
Address
131 Dartmouth Street
3rd Floor
Boston, MA 02116
3rd Floor
Boston, MA 02116
Country
Year Founded
Business Description
Sector
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company’s...
more